| scholarly article | Q13442814 |
| P356 | DOI | 10.3389/FPHAR.2018.00378 |
| P8608 | Fatcat ID | release_ewmayolkajgalpp3nnhpd23t7i |
| P932 | PMC publication ID | 5977984 |
| P698 | PubMed publication ID | 29881347 |
| P2093 | author name string | Na Lin | |
| Weijie Li | |||
| Xiaoyue Wang | |||
| Quan Jiang | |||
| Qiuyan Guo | |||
| Yanqiong Zhang | |||
| Hailong Wang | |||
| Guangyao Li | |||
| Xia Mao | |||
| P2860 | cites work | MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. | Q54387126 |
| Guidelines for the management of rheumatoid arthritis: 2002 Update | Q56212157 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Comparison ofTripterygium wilfordiiHook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial | Q57603196 | ||
| Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray | Q58412739 | ||
| The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α | Q84281957 | ||
| SUMO-conjugating enzyme UBC9 promotes proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis | Q87301070 | ||
| Alterations of plasma glycosaminoglycan profile in patients with rheumatoid arthritis in relation to disease activity | Q87414607 | ||
| Human MicroRNA targets | Q21563637 | ||
| Role of histone H2A ubiquitination in Polycomb silencing | Q24305090 | ||
| Protein complexes and functional modules in molecular networks | Q24683305 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity | Q28255255 | ||
| Relating whole-genome expression data with protein-protein interactions | Q30669147 | ||
| A Markov random field model for network-based analysis of genomic data | Q31111756 | ||
| Network-constrained regularization and variable selection for analysis of genomic data | Q31148172 | ||
| Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor? | Q33700730 | ||
| Future therapeutic targets in rheumatoid arthritis? | Q33841419 | ||
| Identifying cancer biomarkers by network-constrained support vector machines | Q34047245 | ||
| Modularity detection in protein-protein interaction networks | Q34114009 | ||
| A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety. | Q34167879 | ||
| Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis | Q34473650 | ||
| Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway | Q34630091 | ||
| KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor | Q34967352 | ||
| Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα | Q35225741 | ||
| Effects of anti-rheumatic herbal medicines on cellular adhesion molecules | Q35548632 | ||
| MicroRNA Screening and the Quest for Biologically Relevant Targets | Q35590504 | ||
| The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? | Q35680138 | ||
| Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis | Q36076386 | ||
| Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients | Q36955334 | ||
| The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes | Q37093897 | ||
| Chondroitin Sulfate and Abnormal Contact System in Rheumatoid Arthritis | Q37784319 | ||
| Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis. | Q39020455 | ||
| Toxicity of triptolide and the molecular mechanisms involved | Q39237694 | ||
| Precision Medicine in Rheumatoid Arthritis. | Q39436663 | ||
| RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis | Q40214786 | ||
| Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies | Q40273508 | ||
| Identification of Potential Plasma microRNA Stratification Biomarkers for Response to Allogeneic Adipose-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis | Q41889198 | ||
| USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation | Q47974546 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 378 | |
| P577 | publication date | 2018-05-24 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | A Novel Circulating miRNA-Based Model Predicts the Response to Tripterysium Glycosides Tablets: Moving Toward Model-Based Precision Medicine in Rheumatoid Arthritis. | |
| P478 | volume | 9 |
| Q101149163 | Inferences of individual differences in response to tripterysium glycosides across patients with Rheumatoid arthritis using a novel ceRNA regulatory axis |
| Q92063054 | Platelets: emerging facilitators of cellular crosstalk in rheumatoid arthritis |
Search more.